Karapetis CS, Liu H, Sorich MJ, Pederson LD, et al. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials fro Br J Cancer 2024 Feb 24. doi: 10.1038/s41416-024-02604.
PMID: 38402342